Antibodies	An antibody, also known as an immunoglobulin, is a large protein used by the immune system to identify and neutralize foreign objects like bacteria and viruses. The antibody recognizes a unique part of the foreign target, termed an antigen.
Biomarkers	A biomarker to refer to a protein measured in blood whose concentration reflects the severity or presence of some disease state. More generally, a biomarker is anything that can be used as an indicator of a particular disease state.
DMT	Disease Modifying Therapy - Disease Modifying Drugs are a group of compounds which alter the progression of MS. They have been shown to reduce the frequency and severity of relapses and slow the development of disability in some people.
EDSS	Expanded Disability Status Scale - The Expanded Disability Status Scale (EDSS) is a method of quantifying disability in multiple sclerosis. The EDSS quantifies disability in eight Functional Systems (FS) and allows neurologists to assign a Functional System Score (FSS) in each of these.
gMS®Dx	Multiple Sclerosis "Rule-in" Test
gMS®Pro EDSS	Multiple Sclerosis Prognostic Tests according to the severity of the disease
MRI	Magnetic Resonance Imaging is a medical imaging technique used in radiology to visualize detailed internal structures.
MS	Multiple Sclerosis
Phlebotomist	Medical personnel that draws blood sample for testing
PPMS	Primary-Progressive Multiple Sclerosis - PPMS accounts for about 10% of MS diagnoses. This type of MS is characterized by a slow and steady worsening of symptoms. There are relapses in PPMS, but the worsening of symptoms may occasionally speed up, slow down, or even get better for a time.
RPMS	Relapsing-Progressive Multiple Sclerosis - RPMS affects about 5% of people with MS. It is characterized by steady worsening of symptoms and occasional relapses.
RRMS	Relapsing-Remitting Multiple Sclerosis - RRMS accounts for about 85% of all initial MS diagnoses. People with RRMS have isolated relapses. When not having a relapse, someone with RRMS is partially or completely without symptoms.
SPMS	Secondary-Progressive Multiple Sclerosis - About 50% of people with RRMS develop SPMS. This happens gradually, usually within 10 years of the initial MS diagnosis. People with SPMS have fewer and fewer relapses, but begin to have constant, steadily worsening symptoms.